Bermel RA - Search Results

1

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.

Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, Long JD, Natarajan S, Thornell B, Yankey J, Bermel RA, Debbins JP, Huang X, Jagodnik P, Lowe MJ, Nakamura K, Narayanan S, Sakaie KE, Thoomukuntla B, Zhou X, Krieger S, Alvarez E, Apperson M, Bashir K, Cohen BA, Coyle PK, Delgado S, Dewitt LD, Flores A, Giesser BS, Goldman MD, Jubelt B, Lava N, Lynch SG, Moses H, Ontaneda D, Perumal JS, Racke M, Repovic P, Riley CS, Severson C, Shinnar S, Suski V, Weinstock-Guttman B, Yadav V, Zabeti A; NN102/SPRINT-MS Trial Investigators. Fox RJ, et al. Among authors: bermel ra. N Engl J Med. 2018 Aug 30;379(9):846-855. doi: 10.1056/NEJMoa1803583. N Engl J Med. 2018. PMID: 30157388 Free PMC article. Clinical Trial.

2

A semiautomated measure of whole-brain atrophy in multiple sclerosis.

Bermel RA, Sharma J, Tjoa CW, Puli SR, Bakshi R. Bermel RA, et al. J Neurol Sci. 2003 Apr 15;208(1-2):57-65. doi: 10.1016/s0022-510x(02)00425-2. J Neurol Sci. 2003. PMID: 12639726

3

Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity.

Bermel RA, Puli SR, Rudick RA, Weinstock-Guttman B, Fisher E, Munschauer FE 3rd, Bakshi R. Bermel RA, et al. Arch Neurol. 2005 Sep;62(9):1371-6. doi: 10.1001/archneur.62.9.1371. Arch Neurol. 2005. PMID: 16157744 Free PMC article.

4

Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.

Bakshi R, Dandamudi VS, Neema M, De C, Bermel RA. Bakshi R, et al. Among authors: bermel ra. J Neuroimaging. 2005;15(4 Suppl):30S-45S. doi: 10.1177/1051228405283901. J Neuroimaging. 2005. PMID: 16385017 Review.

5

The measurement and clinical relevance of brain atrophy in multiple sclerosis.

Bermel RA, Bakshi R. Bermel RA, et al. Lancet Neurol. 2006 Feb;5(2):158-70. doi: 10.1016/S1474-4422(06)70349-0. Lancet Neurol. 2006. PMID: 16426992 Review.

6

Interferon-beta treatment for multiple sclerosis.

Bermel RA, Rudick RA. Bermel RA, et al. Neurotherapeutics. 2007 Oct;4(4):633-46. doi: 10.1016/j.nurt.2007.07.001. Neurotherapeutics. 2007. PMID: 17920544 Free PMC article. Review.

7

Picturing injury and recovery with diffusion tensor imaging: the eyes have it.

Bermel RA, Fox RJ. Bermel RA, et al. Neurology. 2009 Feb 17;72(7):584-5. doi: 10.1212/01.wnl.0000336559.52816.16. Epub 2008 Dec 10. Neurology. 2009. PMID: 19073946 No abstract available.

8

Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.

Bermel RA, Weinstock-Guttman B, Bourdette D, Foulds P, You X, Rudick RA. Bermel RA, et al. Mult Scler. 2010 May;16(5):588-96. doi: 10.1177/1352458509360549. Epub 2010 Feb 18. Mult Scler. 2010. PMID: 20167591 Clinical Trial.

9

Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy.

Bermel RA, Rae-Grant AD, Fox RJ. Bermel RA, et al. Mult Scler. 2010 Nov;16(11):1335-40. doi: 10.1177/1352458510377334. Epub 2010 Jul 29. Mult Scler. 2010. PMID: 20670982

10

MRI in multiple sclerosis.

Bermel RA, Fox RJ. Bermel RA, et al. Continuum (Minneap Minn). 2010 Oct;16(5 Multiple Sclerosis):37-57. doi: 10.1212/01.CON.0000389933.77036.14. Continuum (Minneap Minn). 2010. PMID: 22810597

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters